Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Croatian Medical Journal|April 17, 2003
Sphingoid bases as possible diagnostic parametersSlavica Ribar, Marko Mesaric, Mirela Sedic
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2012
Using functional genomics to identify drug targets: a Dupuytren's disease exampleMirela Sedic, Sandra Kraljevic Pavelic, Karlo Hock
Molecular Cancer|February 24, 2011
Metastasis: new perspectives on an old problemSandra Kraljevic Pavelic, Mirela Sedic, Hrvojka Bosnjak, et al.
Cancer Treatment Reviews|October 31, 2006
Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view?Sandra Kraljevic, Mirela Sedic, Mike Scott, et al.
Frontiers in Bioscience (Landmark Edition)|December 29, 2009
Functional genomics in identification of drug targets in Dupuytren's contractureMirela Sedic, Davor Jurisic, Zdenko Stanec, et al.
Molecular Cancer Therapeutics|July 23, 2008
Differential antiproliferative mechanisms of novel derivative of benzimidazo[1,2-alpha]quinoline in colon cancer cells depending on their p53 statusMirela Sedic, Miroslav Poznic, Peter Gehrig, et al.
The Journal of Pathology|December 18, 2008
An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's diseaseSandra Kraljevic Pavelic, Mirela Sedic, Karlo Hock, et al.
Electrophoresis|July 7, 2011
Plasma biomarker identification in S-adenosylhomocysteine hydrolase deficiencyMirela Sedic, Sandra Kraljevic Pavelic, Mario Cindric, et al.
Biochemical and Biophysical Research Communications|August 25, 2014
Label-free mass spectrometric profiling of urinary proteins and metabolites from paediatric idiopathic nephrotic syndromeMirela Sedic, Lee A Gethings, Johannes P C Vissers, et al.
Pageof 1